innoscripta SE (ISIN: DE000A40QVM8) has expanded its international footprint by launching operations in the United Kingdom, following its successful market entry into France in April 2026. The company has established a dedicated local sales team and secured its first UK customer, a software company with annual revenues in the mid-double-digit million euro range. This customer has selected innoscripta's SaaS platform Clusterix, which has been fully adapted to UK regulatory requirements, to support its R&D tax relief claims.
Clusterix enables companies to systematically capture R&D projects, working hours and eligible costs while creating a comprehensive, audit-ready documentation trail. This capability is increasingly critical as HM Revenue & Customs (HMRC) has substantially tightened its documentation and compliance requirements for R&D tax relief claims in recent years. The platform helps businesses navigate these stricter rules, reducing the risk of rejected claims or penalties.
With annual R&D tax reliefs of approximately EUR 8.7 billion (around 0.3% of GDP), the United Kingdom represents a market roughly seven times larger than Germany and, alongside France, is one of Europe's largest R&D tax incentive markets. innoscripta's expansion into the UK positions it to capture a significant share of this market. The company reports that several additional customer engagements are currently at an advanced stage of negotiations, and it plans to significantly expand both its UK sales organization and customer base by the end of the year.
The timing of the expansion aligns with HMRC's increased scrutiny of R&D tax relief claims. By providing a digital solution that ensures compliance and thorough documentation, innoscripta aims to help UK businesses maximize their claims while minimizing the risk of audits or rejections. The UK market's size and regulatory environment make it a strategic priority for innoscripta's growth.
This announcement follows the company's recent market entry into France, as detailed in a news release dated 15 April 2026. The UK launch underscores innoscripta's commitment to becoming a leading provider of R&D management software across Europe. The company's Clusterix platform is designed to streamline the entire R&D lifecycle, from project initiation to tax relief submission, making it an attractive tool for firms seeking to optimize their innovation investments.
For further information, contact innoscripta SE at ir@innoscripta.de or the press contact edicto GmbH at +49 69 905505 56 or innoscripta@edicto.de.
